Author: OXB

Posted Date:

March 27, 2026

OXB recognised as ‘Most Innovative CDMO (Cell & Gene)’ at 2026 CDMO Leadership Awards

OXB

March 27, 2026
OXB enters into licensing agreement with Viral Vector Manufacturing Facility (VVMF), providing access to its AAV and LV viral vector platforms

OXB

March 18, 2026
Full year Trading Update and Notice of Results

OXB

February 24, 2026